Sava Technologies today announced the first 10-day clinical evidence for its microsensor-based continuous glucose monitor (CGM).
AZoSensors on MSN
Sava Reports World-First 10-Day Clinical Evidence for Continuous Glucose Monitoring via Proprietary Microsensor Technology
Sava Technologies, the London-based startup pioneering real-time molecular health monitoring, today reports the world's first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results